Biogen Inc. (BIIB) Presents at Cowen 39th Annual Health Care Conference (Transcript) [Seeking Alpha]
Biogen Inc. (BIIB)
Last biogen inc. earnings: 4/22 07:12 am
Check Earnings Report
US:NASDAQ Investor Relations:
biogen.com/en_us/investors.html
Company Research
Source: Seeking Alpha
Biogen Inc. (BIIB) Presents at Cowen 39th Annual Health Care Conference (Transcript) Biogen Inc. (NASDAQ: BIIB Company Participants Michel Vounatsos - CEO Conference Call Participants Phil Nadeau - Cowen & Company Good morning, and welcome once again to Cowen & Company’s 39th Annual Healthcare Conference. I am Phil Nadeau, one of the biotech analysts here at Cowen. And it’s my pleasure to introduce one of our first companies, Biogen, one of the luminaries in the industry. We’re going to do a fireside chat with CEO, Michel Vounatsos. Michel, do you want to start with maybe some opening remarks? Certainly. So, good morning everybody, and thank you for having Biogen and me. We may make some forward-looking statement, so I refer you back to our SEC filing. 2018 was a very good year. Top line, double-digit; bottom line, even stronger. And I would say, more importantly, we have enriched and advanced our pipeline portfolio very well beyond aducanumab. But for aducanumab also, we increased th
Show less
Read more
Impact Snapshot
Event Time:
BIIB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIIB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIIB alerts
High impacting Biogen Inc. news events
Weekly update
A roundup of the hottest topics
BIIB
News
- Alzheimer's Therapeutics Market Size Expected to Surpass USD 8.18 Bn by 2032 [Yahoo! Finance]Yahoo! Finance
- Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at UBS Group AG from $250.00 to $214.00. They now have a "neutral" rating on the stock.MarketBeat
- Global Pulmonary Fibrosis Biomarkers Market Size To Exceed USD 6.1 Billion By 2033 | CAGR of 4.3% [Yahoo! Finance]Yahoo! Finance
- Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Bank of America Co. from $280.00 to $260.00. They now have a "neutral" rating on the stock.MarketBeat
- Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at JPMorgan Chase & Co. from $270.00 to $240.00. They now have a "neutral" rating on the stock.MarketBeat
BIIB
Earnings
- 2/14/24 - Miss
BIIB
Sec Filings
- 4/12/24 - Form PRE
- 4/3/24 - Form 4
- 4/3/24 - Form 4
- BIIB's page on the SEC website